MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.
Location: United States, Georgia, Marietta
Employees: 501-1000
Phone: +1 770-651-9100
Total raised: $150M
Founded date: 2008
Investors 3
Date | Name | Website |
- | The Trelys... | trelys.com |
16.07.2020 | EW Healthc... | ewhealthca... |
- | Southeast ... | southeasti... |
Funding Rounds 1
Date | Series | Amount | Investors |
02.07.2020 | - | $150M | - |
Mentions in press and media 9
Date | Title | Description | Source |
13.03.2024 | MIMEDX Introduces E-Commerce and Account Management Platform | - | globenewsw... |
12.03.2024 | Global Skin Grafting Device Market Size to Surpass US$ 1,519... | Global Skin Grafting Device Market size is expected to reach US$ 1,519.0 Million by 2030, from US$ 9... | einpresswi... |
02.07.2020 | MiMedx Announces Concurrent $150 Million Private Equity and ... | Jul 02 2020 Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Ca... | ewhealthca... |
02.07.2020 | MIMEDX GROUP, INC. MiMedx Announces Concurrent $150 Million... | Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Managem... | marketscre... |
11.01.2018 | MiMedx CEO, short seller face off at J.P. Morgan healthcare ... | The biopharma and healthcare presentations at the J.P. Morgan Healthcare conference tend to be fairl... | medcitynew... |
10.11.2017 | The so-called 'Trump of Georgia' is raining lawsuits on shor... | Advertisement YouTube, CNBC Pete Petit, the CEO of MiMedx. Pete Petit, the CEO of MiMedx, which make... | businessin... |
16.01.2017 | Tom Price’s top backer told employees to give to PAC | A spokesman for Trump’s transition said Price had no knowledge of “internal issues” at MiMedx. He ac... | medcitynew... |
- | Tom Price’s top backer told employees to give to PAC | Committee chair Rep. Tom Price (R-Georgia) speaks during a U.S. House Budget Committee session in Ma... | medcitynew... |
- | MiMedx CEO, short seller face off at J.P. Morgan healthcare ... | The biopharma and healthcare presentations at the J.P. Morgan Healthcare conference tend to be fairl... | medcitynew... |